(Sharecast News) - Two AstraZeneca drugs have been given the green light in America to treat high blood pressure and breast cancer, the blue chip confirmed on Monday.
Baxfendy has been approved by the US Food and Drug Administration as a first-in-class aldosterone synthase inhibitor for the treatment of hypertension in...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE